- Home
- DTF vs PMVP Comparison
DTF vs PMVP Comparison
Compare DTF & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTF
- PMVP
- Stock Information
- Founded
- DTF 1991
- PMVP 2013
- Country
- DTF United States
- PMVP United States
- Employees
- DTF N/A
- PMVP N/A
- Industry
- DTF Investment Managers
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- DTF Finance
- PMVP Health Care
- Exchange
- DTF Nasdaq
- PMVP Nasdaq
- Market Cap
- DTF 78.2M
- PMVP 71.9M
- IPO Year
- DTF N/A
- PMVP 2020
- Fundamental
- Price
- DTF $11.19
- PMVP $0.92
- Analyst Decision
- DTF
- PMVP Strong Buy
- Analyst Count
- DTF 0
- PMVP 1
- Target Price
- DTF N/A
- PMVP $5.00
- AVG Volume (30 Days)
- DTF 21.1K
- PMVP 313.5K
- Earning Date
- DTF 01-01-0001
- PMVP 05-09-2025
- Dividend Yield
- DTF 3.64%
- PMVP N/A
- EPS Growth
- DTF N/A
- PMVP N/A
- EPS
- DTF 0.44
- PMVP N/A
- Revenue
- DTF N/A
- PMVP N/A
- Revenue This Year
- DTF N/A
- PMVP N/A
- Revenue Next Year
- DTF N/A
- PMVP N/A
- P/E Ratio
- DTF $24.34
- PMVP N/A
- Revenue Growth
- DTF N/A
- PMVP N/A
- 52 Week Low
- DTF $10.29
- PMVP $0.81
- 52 Week High
- DTF $11.19
- PMVP $1.85
- Technical
- Relative Strength Index (RSI)
- DTF 52.43
- PMVP 49.14
- Support Level
- DTF $11.14
- PMVP $0.85
- Resistance Level
- DTF $11.21
- PMVP $0.94
- Average True Range (ATR)
- DTF 0.05
- PMVP 0.06
- MACD
- DTF 0.00
- PMVP 0.01
- Stochastic Oscillator
- DTF 55.00
- PMVP 82.18
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.